These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8821056)

  • 21. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
    Meyer M; Johansen J; Gramsbergen JB; Johansen TE; Zimmer J
    Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.
    Kupsch A; Oertel WH; Earl CD; Sautter J
    J Neural Transm Suppl; 1995; 46():193-207. PubMed ID: 8821056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (I)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Nov 16-30; 41(10):604-14. PubMed ID: 16288424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cell therapy and other neuroregenerative strategies in Parkinson's disease (II)].
    Mínguez-Castellanos A; Escamilla-Sevilla F
    Rev Neurol; 2005 Dec 1-15; 41(11):684-93. PubMed ID: 16317638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging restorative treatments for Parkinson's disease.
    Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology].
    Sautter J; Kupsch A; Oertel WH; Earl CD
    Zentralbl Neurochir; 1995; 56(4):161-7. PubMed ID: 8571694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracerebral transplantation of genetically engineered cells for Parkinson's disease: toward clinical application.
    Yasuhara T; Date I
    Cell Transplant; 2007; 16(2):125-32. PubMed ID: 17474294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease.
    Lapchak PA
    Mov Disord; 1998; 13 Suppl 1():49-54. PubMed ID: 9613719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
    Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D
    Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease.
    Lindvall O; Kokaia Z
    Trends Pharmacol Sci; 2009 May; 30(5):260-7. PubMed ID: 19362379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural transplantation in Parkinson's disease.
    Lindvall O
    Novartis Found Symp; 2000; 231():110-23; discussion 123-8, 145-7. PubMed ID: 11131534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotrophic factor therapy for Parkinson's disease.
    Rangasamy SB; Soderstrom K; Bakay RA; Kordower JH
    Prog Brain Res; 2010; 184():237-64. PubMed ID: 20887879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biotherapies and Parkinson's disease].
    Cesaro P; Fenelon G; Remy P
    Rev Neurol (Paris); 2009 Nov; 165(11):857-62. PubMed ID: 19487002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of growth factors for the treatment of Parkinson's disease.
    Yasuda T; Mochizuki H
    Expert Rev Neurother; 2010 Jun; 10(6):915-24. PubMed ID: 20518608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental clinical transplantation in patients with Parkinson disease. Experimental background and clinical picture].
    Ostergaard K; Rasmussen JZ
    Ugeskr Laeger; 1991 Dec; 153(50):3554-8. PubMed ID: 1776197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell transplantation and gene therapy in Parkinson's disease.
    Wakeman DR; Dodiya HB; Kordower JH
    Mt Sinai J Med; 2011; 78(1):126-58. PubMed ID: 21259269
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.